The fourth annual META:PHI conference took place online on September 24-25, 2021. Many thanks to all speakers, moderators, facilitators, and attendees!

Agenda

Some presentation slides are available for download; please click on the title to view.

Friday, September 24

8:00-8:30 Sign-in and lobby chat
8:30-9:00 Welcome
Kate Hardy, Network Director, META:PHI
Meldon Kahan, Medical Director, META:PHI
9:00-10:00 Plenary
Supporting First Nations right to health: What is the critical path?
Dr. Carol Hopkins OC, Chief Executive Officer, Thunderbird Partnership Foundation
10:00-11:00 Session 1A
Emerging drugs of abuse: Implications for clinical practice
Pamela Kaduri MD CCFP 
Session 1B
Advancing the meaningful involvement, expertise, and experiences of people who use drugs within research
Frank Crichlow, CAPUD
Ashley Smoke, Unity Health Researcher, Ontario Network of People who Use Drugs Co-Founder
Colin H. Johnson Cert AODA, Toronto Harm Reduction Alliance, Unity Health Researcher
Workshop 1, part 1
Digging in to buprenorphine: Initiating and managing buprenorphine in ambulatory, ED, and inpatient settings
Katie Dunham BSc Hons BScN MN NP-PHC
Melissa Holowaty PhD MD CCFP (AM)
Robyn Nocilla 
BScN MSc NP-PHC
Mike Postic 
MSc NP-Adult
Elizabeth Shouldice
MD MPH CCFP (EM) FCFP
Jennifer Wyman 
MD CCFP FCFP DABAM MPH
11:00-11:15 Break
11:15-12:15 Session 2A
Desperate times call for desperate measures: Breaking the barrier for treatment of OUD using macrodosing & depot buprenorphine
Louisa Marion-Bellemare MD CCFP 
Julie Samson
MD CCFP (EM)
Timmins District Hospital Opioid Withdrawal Protocol

Timmins District Hospital Admission Order Set
Session 2B
Impacts of the COVID pandemic on access to opioid agonist treatment, safer opioid supply and harm reduction services among people who use drugs in Toronto
Gillian Kolla
PhD, Centre for Drug Policy Evaluation
Jeanette Bowles
PhD, Centre for Drug Policy Evaluation
Workshop 1, part 2
Digging in to buprenorphine: Initiating and managing buprenorphine in ambulatory, ED, and inpatient settings
Katie Dunham BSc Hons BScN MN NP-PHC
Melissa Holowaty PhD MD CCFP (AM)
Robyn Nocilla 
BScN MSc NP-PHC
Mike Postic 
MSc NP-Adult
Elizabeth Shouldice 
MD MPH CCFP (EM) FCFP
Jennifer Wyman 
MD CCFP FCFP DABAM MPH
12:15-1:00 Lunch
1:00-2:30 Panel discussion – OAT during COVID: What have we learned and where should we be heading?
Moderator: Vincent Lam MD CCFP (AM) ASAM CSAM
1. Evaluating the impact of the Ontario COVID-19 opioid agonist therapy guidelines
Pamela Leece MD MSc CCFP FRCPC
2. Changing patterns of OAT and associated outcomes during COVID
Tara Gomes PhD MHSc, Principal Investigator, Ontario Drug Policy Research Network
3. Perspectives of people who use opioids and prescribers on opioid agonist therapy during the pandemic: Findings from the ALT-POP study
Sean LeBlanc, DUAL Founder, CAPUD Board Member, Community Researcher
Samantha Young
MD FRCPC
2:30-3:15 Poster presentations (see below)
3:15-4:15 Session 3A
Opioid agonist treatment and the opioid crisis
Meldon Kahan MD CCFP FRCPC
Session 3B
Pandemic innovation: RAAM digital front door
Kim Corace PhD C.Psych
Melanie Willows BSc MD CCFP (AM) CCSAM DABAM
Workshop 2, part 1
Strengthening non-stigmatizing relationships in overdose response work in Toronto
Sarah Greig, Manager, Moss Park OPS
4:15-4:30 Break
4:30-5:30 Session 4A
Re-imagining philosophies of care: Hiring, training, and mentorship of nurses in CTS
Erin Telegdi RN, South Riverdale CHC
Lara Small RN, South Riverdale CHC
Jessica Arteaga RN, South Riverdale CHC
Sushi Rosborough, Overdose Response Worker, South Riverdale CHC
Session 4B
STOPS - A journey of grassroots overdose prevention from Northeastern Ontario
Karla Ghartey, STOPS Program
Crystal Kimewon, STOPS Program
Marie Pollock, STOPS Program
Workshop 2, part 2
Strengthening non-stigmatizing relationships in overdose response work in Toronto
Sarah Greig, Manager, Moss Park OPS
5:30-6:30 Day 1 wrap-up and networking sessions
Session A
Inpatient medicine
Lisa Bromley MD CCFP (AM) FCFP
Session B
Nurse practitioners
Katie Dunham
BSc Hons BScN MN NP-PHC
Session C
Emergency medicine
Hasan Sheikh CCFP (EM) MPA
Session D
Networking in RAAM clinics
Christina Henry RN BScN BA
Session E
Research
Meldon Kahan
MD CCFP FRCPC
Anita Srivastava
MD MSc CCFP
Session F
Rural settings
Josh Richardson
RP RPN Psych Cert BAH

 

 Saturday, September 25

8:00-8:30 Sign-in and lobby chat
8:30-9:30 Session 5A
Medically supported alcohol withdrawal management: Outpatient and detox perspectives
David Peterson NP-PHC MSc BNSc BPHE BSc
Shawn Dookie
NP-PHC RN (EC) BSc MPH
Session 5B
Addressing stigma through clinical judgment: Strategies for working with families
Oona St-Amant RN PhD
Angie Hamilton, Executive Director, Families for Addiction Recovery
Brynlea Barbeau MD
Workshop 3, part 1
Increasing access to aftercare through peer support: An interactive workshop
Elizabeth Tremblay, Mentor/Mentee Canada
Fiona Wilson, St. Joseph’s Hospital Hamilton
Asante Haughton, Reach Out Response Network, Stella’s Place
Dana Muma, Cambridge Memorial Hospital
9:30-9:45 Break
9:45-10:45 Session 6A
Downtown east community-led trauma informed overdose response curriculum
Seff Pinch, South Riverdale CHC
Sunny Sultan, South Riverdale CHC
Session 6B
Peer support in the emergency department: An innovative way to complement care for young adults presenting with mental health and substance use
Yolanda-Nicole Delmonte, Peer Support Worker, RBC Pathway to Peers, Mount Sinai Hospital
Allison Dunning, Founder and Principal Consultant, Dunning Consulting
Christine Bradshaw
, Program Manager, RBC Pathway to Peers, ED Social Worker, Mount Sinai Hospital
Workshop 3, part 2
Increasing access to aftercare through peer support: An interactive workshop
Elizabeth Tremblay, Mentor/Mentee Canada
Fiona Wilson, St. Joseph’s Hospital Hamilton
Asante Haughton, Reach Out Response Network, Stella’s Place
Dana Muma, Cambridge Memorial Hospital
10:45-12:15 Grief and loss in the overdose crisis: Self-awareness, self-care, and collective care
Yvette Perreault
, Team Lead, Good Grief Care Consultants
12:15-1:15 Lunch
1:15-2:15 Session 7A
5 years of treating perinatal substance use disorder at Kingston Health Sciences Centre
Adam Newman MD FCFP (AM) CCSAM
Session 7B
From grief to advocacy: Family journeys to demanding safe supply, decriminalization and harm reduction
Christine Wingate, Ontario Director, Moms Stop the Harm
Missy McLean
, Ontario Director, Moms Stop the Harm
Workshop 4, part 1
Methadone treatment for people who use fentanyl: Using case discussions to explore the META:PHI guidelines
Lisa Bromley MD CCFP (AM) FCFP
Robin Lennox MD CCFP
Meredith MacKenzie MD BSc CCFP (AM) FCFP
Andrew McLeod
Lori Regenstreif
MD CCFP (AM) FCFP MScCH (AMH) CISAM
Anita Srivastava MD MSc CCFP
2:15-2:30 Break
2:30-3:30 Session 8A
Monthly depot buprenorphine XL:  The first 100 patients (London RAAM Clinic)
Ken Lee MD MCFP (AM)
Session 8B
A rural approach to the opioid crisis
Micayla Ahearn
MD
Victoria Burke, ROCK Outreach Worker
Sean Lee-Popham RN, Harm Reduction Lead, Bancroft Community FHT
Ellen Buck-McFadyen PhD, Trent University School of Nursing
Workshop 4, part 2
Methadone treatment for people who use fentanyl: Using case discussions to explore the META:PHI guidelines
Lisa Bromley MD CCFP (AM) FCFP
Robin Lennox MD CCFP
Meredith MacKenzie MD BSc CCFP (AM) FCFP
Andrew McLeod
Lori Regenstreif
MD CCFP (AM) FCFP MScCH (AMH) CISAM
Anita Srivastava MD MSc CCFP
3:30-4:15 Poster presentations (see below)
4:15-5:15 Session 9A
Drug decriminalization
Matthew Bonn, Program Manager, CAPUD
Sandra Ka Hon Chu, Co-Executive Director, HIV Legal Network
Session 9B
The structure, growth, and development of an addiction rural service: An inter-professional multi-regional community-wide approach
Connie Foster NP-PHC MSc
Katie Hogue NP-PHC
Session 9C
Inpatient naloxone kit distribution: Our first steps into hospital-based harm reduction initiatives
Michael Roach, NE Ontario Regional Lead, RAAM and AMCT
Paola Nikodem, Regional Education and Quality Lead for Addictions Services, Health Sciences North
5:15-5:30 Day 2 wrap-up

 

Poster presentations

Friday, September 24
2:30-3:15
The lived experience of recovering from substance use disorder: A dual perspective
Courtney Langlois
BScN RN MS3

Does employing a drug dispensing machine improve patient outcomes in an OAT program for patients with severe opioid use disorder: A prospective study
Jonny Grek MD, Northern Ontario School of Medicine
Kyla Vanderzwet MD, Norther Ontario School of Medicine

Cannabis use disorder symptoms correlate with depression in a racial minority sample but not in a white sample
Talia Tissera BSc, St. Joseph’s Healthcare Hamilton

Withdrawal in the community:  Implementing evidence-based withdrawal management in a community setting
Stephanie Rochon RPHT, BHN RAAM, Brant Community Healthcare System
Lauren Kielstra MD
Tanya Hauck MD PhD FRCPC

Evaluation of a RAAM program
Lily Xu BHA
Delmar Donald MD CCSAM

Exploring the relation between cannabis use disorder and insomnia in youth with concurrent disorders
Stephanie Penta BSc, St. Joseph’s Healthcare Hamilton

Breaking new ground: Addictions medicine unit at Health Sciences North
Tara Leary MD
Russell Landry, Regional Lead MCRRT and Safe Bed Programs, Health Sciences North
Shannon Knowlan, Clinical Manager, Addiction Medicine Unit
Saturday, September 25
3:30-4:15
Public health outcomes and clinical interventions to improve health outcomes of people who use inhalants: A systematic review
Alisha Atri, Department of Research Methods, Evidence, and Impact, McMaster University; Medical Health Intern, Labrador-Grenfell Health

Prescribing characteristics associated with opioid overdose following buprenorphine taper
Nikki Bozinoff MD CCFP (AM)

Tackling the opioid crisis by developing a curriculum for postgraduate medical education and continuous professional development on pain management and substance use disorder in Canada
Lisa Graves MD, Western Michigan University Homer Stryker M.D. School of Medicine

Exploring the relation between attention deficit hyperactivity disorder, drug use, and impulsivity in individuals with concurrent disorders
Mina Pichtikova BSc, St. Joseph’s Healthcare Hamilton

Substance use treatment in fetal alcohol spectrum disorder populations
Aamena Kapasi PhD, Post-Doctoral Fellow, University of Alberta

Trends in daily dispensed immediate release hydromorphone prescribing across Ontario: A descriptive analysis from 2016-2020
Samantha Young MD FRCPC

 

 

Accreditation

This conference has been certified by Continuing Professional Development, Faculty of Medicine, University of Toronto for up to 16.0 Mainpro+ (1 credit/hour) Group Learning credits and up to 16.0 Royal College Maintenance of Certification Section 1 hours.

 

Scientific Planning Committee

Thank you to our conference planning committee for their input and expertise in the planning of this event:

Rachel Alexander BAH
Leslie Buckley
 MD MPH FRCPC
Katie Dunham BSc Hons, BScN, MN, NP-PHC
Kate Hardy MSW RSW
Christina Henry RN BScN BA
Louisa Marion-Bellemare MD CCFP (EM)
Josh Richardson RP RPN Psych Cert BAH
Michael Roach RN MN
Hasan Sheikh MD CCFP (EM) MPA
Jennifer Wyman MD CCFP FCFP DABAM MPH
Maria Zhang BScPhm, PharmD